Medtronic Inc. recalls ICM LNQ22 LINQ II
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.
- Products
-
- ICM LNQ22 LINQ II
- Company
- Medtronic Inc.
- Where it was sold
-
US and Australia, Austria, Belgium, Brunei Darussalam, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Macao, Malaysia, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Puerto Rico, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom
States: Puerto Rico
- Barcodes
00763000060374007630000603810076300055399900763000554002007630006137470076300063511400763000871642- Units affected
- 64,739 units
- About this recall
- ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor